MacroGenics, Inc. - Common Stock (NQ:MGNX)

2.380 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MacroGenics, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday ↗

February 26, 2024

U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Shares of Surgery Partners, Inc. (NASDAQ: SGRY) fell sharply during Monday’s session following weak...

Via Benzinga

Topics Stocks

Decoding 4 Analyst Evaluations For Macrogenics ↗

February 14, 2024

Via Benzinga

MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 2/12

February 12, 2024

Via Investor Brand Network

MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 2/6

February 06, 2024

Via Investor Brand Network

MicroMarvel MacroGenics Confuses Wall Street ↗

February 05, 2024

100% technical buy signals. 15 new highs and up 66.53% last month. 280.00+ Weighted Alpha

Via Talk Markets

MacroGenics to Participate in Upcoming Investor Conference

February 02, 2024

From MacroGenics, Inc.

Via GlobeNewswire

MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 2/1

February 01, 2024

Via Investor Brand Network

Demystifying Macrogenics: Insights From 5 Analyst Reviews ↗

January 24, 2024

Via Benzinga

MacroGenics Inc. (NASDAQ: MGNX) is a Stock Spotlight on 1/23

January 23, 2024

Via Investor Brand Network

World Acceptance Posts Upbeat Earnings, Joins Kaman, Spirit Airlines And Other Big Stocks Moving Higher On Friday ↗

January 19, 2024

U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday. Shares of World Acceptance Corporation (NASDAQ: WRLD) rose sharply during Friday’s session following upbeat...

Via Benzinga

Topics Stocks

The 3 Most Undervalued Biotech Stocks to Buy in January ↗

January 15, 2024

These are a number of undervalued biotech companies that investor should possibly look to add to their portfolios.

Via InvestorPlace

MacroGenics to Participate in Upcoming Investor Conference

January 08, 2024

From MacroGenics, Inc.

Via GlobeNewswire

Forecasting The Future: 4 Analyst Projections For Macrogenics ↗

December 20, 2023

Via Benzinga

Earnings Scheduled For November 6, 2023 ↗

November 06, 2023

Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.

Via Benzinga

A Preview Of Macrogenics's Earnings ↗

November 03, 2023

Via Benzinga

Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

December 20, 2023

Steelcase Inc. (NYSE: SCS) shares moved higher during Wednesday's session following quarterly results.

Via Benzinga

Toro Posts Upbeat Results, Joins Clear Channel Outdoor, Marathon Digital And Other Big Stocks Moving Higher On Wednesday ↗

December 20, 2023

U.S. stocks traded mixed, with the Dow Jones index falling around 50 points on Wednesday.

Via Benzinga

Topics Stocks

Top 4 Health Care Stocks That May Crash This Month ↗

December 20, 2023

As of Dec. 20, 2023, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Via Benzinga

EnerSys To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

December 20, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar ↗

December 17, 2023

While the broader healthcare sector offers myriad opportunities, these undervalued biotech picks could offer robust upside.

Via InvestorPlace

Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday ↗

November 07, 2023

U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

November 07, 2023

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.

Via Benzinga

MacroGenics (MGNX) Q3 2023 Earnings Call Transcript ↗

November 07, 2023

MGNX earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

MacroGenics to Participate in Upcoming Investor Conferences

November 02, 2023

From MacroGenics, Inc.

Via GlobeNewswire

MacroGenics Announces Date of Third Quarter 2023 Financial Results Conference Call

October 31, 2023

From MacroGenics, Inc.

Via GlobeNewswire

Elli Lilly Joins Big Pharma’s Multi-Billion-Dollar Oncology Race

October 10, 2023

Large pharmaceutical companies are increasingly investing in cancer treatment stocks, driven by the promise of medical breakthroughs and financial rewards. Eli Lilly became the latest Big Pharma giant...

Via PressReach

MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program

September 05, 2023

From MacroGenics, Inc.

Via GlobeNewswire

MacroGenics to Participate in Upcoming Investor Conferences

August 31, 2023

From MacroGenics, Inc.

Via GlobeNewswire

3 Under-the-Radar Biotech Stocks to Buy in 2023 ↗

August 19, 2023

All three biotech companies focus on oncology therapies.

Via The Motley Fool

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

August 10, 2023

Via Benzinga

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.